| Net Cash Provided by (Used in) Operating Activities |
$10,501,000 |
USD |
-57% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$183,406,000 |
USD |
-15% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$13,607,000 |
USD |
-83% |
Q1 2025 |
Q1 2025 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$158,889,000 |
USD |
-184% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$221,567,000 |
USD |
-50% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Valuation Allowance |
$15,278,000 |
USD |
11% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
$18,183,000 |
USD |
7.5% |
Q4 2024 |
FY 2024 |
| Operating Lease, Liability |
$21,573,000 |
USD |
-14% |
Q3 2025 |
Q3 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$31,887,000 |
USD |
75% |
Q3 2025 |
Q3 2025 |
| Deferred Income Tax Expense (Benefit) |
$58,000 |
USD |
58% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$35,700,000 |
USD |
0.85% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Authorized |
50,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Operating Lease, Payments |
$400,000 |
USD |
0% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$2,905,000 |
USD |
-6.9% |
Q4 2024 |
FY 2024 |
| Share-based Payment Arrangement, Expense |
$12,828,000 |
USD |
11% |
Q3 2025 |
Q3 2025 |
| Interest Expense |
$159,966,000 |
USD |
-6.9% |
Q3 2024 |
Q3 2024 |
| Preferred Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |